- Home
- PMT vs SYRE Comparison
PMT vs SYRE Comparison
Compare PMT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- SYRE
- Stock Information
- Founded
- PMT 2009
- SYRE 2013
- Country
- PMT United States
- SYRE United States
- Employees
- PMT N/A
- SYRE N/A
- Industry
- PMT Real Estate Investment Trusts
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- SYRE Health Care
- Exchange
- PMT Nasdaq
- SYRE Nasdaq
- Market Cap
- PMT 1.2B
- SYRE 1.2B
- IPO Year
- PMT 2009
- SYRE 2016
- Fundamental
- Price
- PMT $14.50
- SYRE $18.33
- Analyst Decision
- PMT Buy
- SYRE Strong Buy
- Analyst Count
- PMT 6
- SYRE 8
- Target Price
- PMT $15.25
- SYRE $51.50
- AVG Volume (30 Days)
- PMT 689.6K
- SYRE 643.4K
- Earning Date
- PMT 04-23-2025
- SYRE 05-08-2025
- Dividend Yield
- PMT 11.22%
- SYRE N/A
- EPS Growth
- PMT N/A
- SYRE N/A
- EPS
- PMT 1.37
- SYRE N/A
- Revenue
- PMT $504,603,000.00
- SYRE N/A
- Revenue This Year
- PMT N/A
- SYRE N/A
- Revenue Next Year
- PMT $1.57
- SYRE N/A
- P/E Ratio
- PMT $10.43
- SYRE N/A
- Revenue Growth
- PMT N/A
- SYRE N/A
- 52 Week Low
- PMT $11.77
- SYRE $17.24
- 52 Week High
- PMT $15.22
- SYRE $47.97
- Technical
- Relative Strength Index (RSI)
- PMT 54.80
- SYRE 38.91
- Support Level
- PMT $14.14
- SYRE $17.50
- Resistance Level
- PMT $14.93
- SYRE $21.03
- Average True Range (ATR)
- PMT 0.29
- SYRE 1.68
- MACD
- PMT -0.06
- SYRE -0.07
- Stochastic Oscillator
- PMT 23.86
- SYRE 22.89
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.